[go: up one dir, main page]

AR118703A2 - FACTOR VII POLIPEPTIDE TO TREAT A DISEASE - Google Patents

FACTOR VII POLIPEPTIDE TO TREAT A DISEASE

Info

Publication number
AR118703A2
AR118703A2 ARP200101072A ARP200101072A AR118703A2 AR 118703 A2 AR118703 A2 AR 118703A2 AR P200101072 A ARP200101072 A AR P200101072A AR P200101072 A ARP200101072 A AR P200101072A AR 118703 A2 AR118703 A2 AR 118703A2
Authority
AR
Argentina
Prior art keywords
treat
disease
factor vii
polipeptide
disorder
Prior art date
Application number
ARP200101072A
Other languages
Spanish (es)
Inventor
Maxine Bauzon
Terry Hermiston
Original Assignee
Coagulant Therapeutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coagulant Therapeutics Corp filed Critical Coagulant Therapeutics Corp
Publication of AR118703A2 publication Critical patent/AR118703A2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se describe un polipéptido del Factor VII que se utiliza para tratar una enfermedad o trastorno que comprende la secuencia aminoacídica de SEQ ID Nº 16.A Factor VII polypeptide that is used to treat a disease or disorder is described that comprises the amino acid sequence of SEQ ID No. 16.

ARP200101072A 2012-12-24 2020-04-16 FACTOR VII POLIPEPTIDE TO TREAT A DISEASE AR118703A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261745674P 2012-12-24 2012-12-24

Publications (1)

Publication Number Publication Date
AR118703A2 true AR118703A2 (en) 2021-10-27

Family

ID=56117356

Family Applications (4)

Application Number Title Priority Date Filing Date
ARP130105071A AR094317A1 (en) 2012-12-24 2013-12-27 SHORT ACTION FACTOR VII POLIPEPTIDES
ARP200101072A AR118703A2 (en) 2012-12-24 2020-04-16 FACTOR VII POLIPEPTIDE TO TREAT A DISEASE
ARP200101074A AR118705A2 (en) 2012-12-24 2020-04-16 FACTOR VII POLIPEPTIDE TO TREAT DISEASES, METHOD FOR PREPARING IT AND COMPOSITION CONTAINING IT
ARP200101073A AR118704A2 (en) 2012-12-24 2020-04-16 FACTOR VII POLIPEPTIDE TO TREAT DISEASES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP130105071A AR094317A1 (en) 2012-12-24 2013-12-27 SHORT ACTION FACTOR VII POLIPEPTIDES

Family Applications After (2)

Application Number Title Priority Date Filing Date
ARP200101074A AR118705A2 (en) 2012-12-24 2020-04-16 FACTOR VII POLIPEPTIDE TO TREAT DISEASES, METHOD FOR PREPARING IT AND COMPOSITION CONTAINING IT
ARP200101073A AR118704A2 (en) 2012-12-24 2020-04-16 FACTOR VII POLIPEPTIDE TO TREAT DISEASES

Country Status (1)

Country Link
AR (4) AR094317A1 (en)

Also Published As

Publication number Publication date
AR094317A1 (en) 2015-07-29
AR118704A2 (en) 2021-10-27
AR118705A2 (en) 2021-10-27

Similar Documents

Publication Publication Date Title
MX2024001192A (en) Anti-lag-3 antibodies and methods of use thereof.
CY1120646T1 (en) ORIGINAL CELLS OF INTERMEDERAL ORIGIN
CY1118885T1 (en) Synthetic peptidoglycans that bind hyaluronic acid, preparations, and methods of use
PE20181076A1 (en) NEW MODULATORS AND METHODS FOR THEIR USE
EA201792613A1 (en) COT MODULATORS AND METHODS OF THEIR APPLICATION
CR20110526A (en) ANTIBODIES ANTI - TNF - ALFA AND ITS USES
MX2021011167A (en) HUMANIZED ANTIBODIES AGAINST HUMAN DIFFERENTIATION GROUP 19 (CD19) AND METHODS OF USE.
MX2020009401A (en) MODIFIED NUCLEOTIDE LINKERS.
MX2021015971A (en) CONSTRUCTIONS OF DNA ANTIBODIES AND METHOD FOR USING THEM.
ES2691070T3 (en) Anti-inflammatory peptides and composition comprising the same
GT201400147A (en) PYRIMIDINES AND FUSIONATED TRIAZINS REPLACED AND ITS USE
AR095977A1 (en) A PROCEDURE TO INCREASE THE FORMATION OF PYROGLUTAMIC ACID OF A PROTEIN
MX2023009421A (en) Dna antibody constructs and method of using same.
MX2015015009A (en) Oral dosing of glp-1 compounds.
MX380772B (en) 3-EPIMERASE.
ES2721309T3 (en) Composition for preparing tagatose and method for preparing tagatose from fructose
CR20170197A (en) PROTEINS OF VARIANTS OF SEQUENCES OF AMINO ACIDS OF CRY1DA1 ACTIVE FOR LEPIDOPTERS
MX2017007105A (en) LIPASE AND POLINUCLEOTID VARIANTS CODING THEM.
MX377149B (en) RECOMBINANT MICROORGANISM FOR THE IMPROVED PRODUCTION OF FINE CHEMICALS.
CY1121067T1 (en) PCSK9 PEPTIDE VACCINE
MX2015007712A (en) Short-acting factor vii polypeptides.
UY34268A (en) METHODS TO INCREASE THE CONTENT OF PROTEINS, OILS AND / OR AMINO ACIDS ON A PLANT
CO2017012397A2 (en) Fragment of human anti-ngf fab antibody
EA201690966A1 (en) NEW CONNECTION FOR THE TREATMENT OF HEAVY HYPOGLYCEMIA
AR118703A2 (en) FACTOR VII POLIPEPTIDE TO TREAT A DISEASE